Singular Genomics Systems, Inc.
Символ: OMIC
NASDAQ
0.4131
USDПазарна цена днес
-0.3255
Съотношение P/E
0.0000
Коефициент PEG
30.60M
MRK Cap
- 0.00%
Доходност на DIV
Singular Genomics Systems, Inc. (OMIC) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 797.41 | 173.9 | 244.6 | 339.2 | |||||
balance-sheet.row.short-term-investments | 543.78 | 157.7 | 170.3 | 138.2 | |||||
balance-sheet.row.net-receivables | 6.26 | 1.6 | 0.9 | 1.1 | |||||
balance-sheet.row.inventory | 58.51 | 13.6 | 18.2 | 3 | |||||
balance-sheet.row.other-current-assets | 2.76 | 1.5 | 4.7 | 4.5 | |||||
balance-sheet.row.total-current-assets | 875.19 | 192.2 | 268.4 | 347.8 | |||||
balance-sheet.row.property-plant-equipment-net | 254.87 | 71.5 | 56.7 | 6.1 | |||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.goodwill-and-intangible-assets | -16.32 | -16.3 | -14.9 | 0 | |||||
balance-sheet.row.long-term-investments | 5.73 | 0.6 | 1.7 | 0.7 | |||||
balance-sheet.row.tax-assets | 15.72 | 15.7 | 13.2 | 0 | |||||
balance-sheet.row.other-non-current-assets | 4.24 | 1.8 | 2.9 | 1.1 | |||||
balance-sheet.row.total-non-current-assets | 264.24 | 73.2 | 59.5 | 7.9 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 1139.43 | 265.5 | 328 | 355.6 | |||||
balance-sheet.row.account-payables | 8.97 | 2.6 | 3.1 | 2.3 | |||||
balance-sheet.row.short-term-debt | 30.03 | 7.8 | 6.3 | 0 | |||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.long-term-debt-total | 239.26 | 67.5 | 52.5 | 9.9 | |||||
Deferred Revenue Non Current | 0.3 | 0.3 | 0.1 | 0 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 15.72 | - | - | - | |||||
balance-sheet.row.other-current-liab | 5.89 | 1.9 | 4.7 | 4.4 | |||||
balance-sheet.row.total-non-current-liabilities | 242.5 | 68.2 | 53.5 | 12.7 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 229.98 | 66.4 | 48.8 | 0 | |||||
balance-sheet.row.total-liab | 302.68 | 86.5 | 67.7 | 19.5 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 355.6 | |||||
balance-sheet.row.common-stock | 0.03 | 0 | 0 | 0 | |||||
balance-sheet.row.retained-earnings | -1210.34 | -337.6 | -242.8 | -151.9 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -0.78 | 0.2 | -0.8 | -0.1 | |||||
balance-sheet.row.other-total-stockholders-equity | 2047.83 | 516.4 | 503.9 | 132.6 | |||||
balance-sheet.row.total-stockholders-equity | 836.75 | 179 | 260.3 | 336.2 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 1139.43 | 265.5 | 328 | 355.6 | |||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-equity | 836.75 | 179 | 260.3 | 336.2 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 1139.43 | - | - | - | |||||
Total Investments | 543.78 | 157.7 | 170.3 | 138.2 | |||||
balance-sheet.row.total-debt | 269.29 | 75.3 | 58.8 | 9.9 | |||||
balance-sheet.row.net-debt | 15.66 | 59.1 | -15.4 | -191.1 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -94.82 | -94.8 | -90.9 | -98.8 | |||||
cash-flows.row.depreciation-and-amortization | 7.22 | 7.2 | 6 | 1.1 | |||||
cash-flows.row.deferred-income-tax | -0.55 | 0.8 | 0 | 4.1 | |||||
cash-flows.row.stock-based-compensation | 11.4 | 11.4 | 13.7 | 9.2 | |||||
cash-flows.row.change-in-working-capital | -2.25 | -2.2 | -16.8 | -2.9 | |||||
cash-flows.row.account-receivables | 0.35 | 0.3 | -0.9 | 0 | |||||
cash-flows.row.inventory | -3.54 | -3.5 | -13.5 | 0 | |||||
cash-flows.row.account-payables | 0.27 | 0.3 | -1.2 | 1.9 | |||||
cash-flows.row.other-working-capital | 1.24 | 2.9 | -1.2 | -4.8 | |||||
cash-flows.row.other-non-cash-items | 5.34 | 4 | 0.9 | 35.5 | |||||
cash-flows.row.net-cash-provided-by-operating-activities | -73.65 | 0 | 0 | 0 | |||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.97 | -1 | -6 | -4.9 | |||||
cash-flows.row.acquisitions-net | -38.33 | 0 | 33.5 | 126 | |||||
cash-flows.row.purchases-of-investments | -183.59 | -183.6 | -174.7 | -195.7 | |||||
cash-flows.row.sales-maturities-of-investments | 198.37 | 198.4 | 141.2 | 69.7 | |||||
cash-flows.row.other-investing-activites | 38.33 | 0 | -33.5 | -126 | |||||
cash-flows.row.net-cash-used-for-investing-activites | 13.81 | 13.8 | -39.6 | -130.9 | |||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | -10.4 | |||||
cash-flows.row.common-stock-issued | 0.71 | 0 | 0.2 | 240.8 | |||||
cash-flows.row.common-stock-repurchased | -0.02 | 0 | -0.5 | 3.6 | |||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -3.6 | |||||
cash-flows.row.other-financing-activites | 0.62 | 0.7 | 1.2 | 141.8 | |||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0.7 | 0.7 | 0.9 | 372.1 | |||||
cash-flows.row.effect-of-forex-changes-on-cash | 57.31 | 0 | 0 | 0 | |||||
cash-flows.row.net-change-in-cash | -59.14 | -59.1 | -125.8 | 189.6 | |||||
cash-flows.row.cash-at-end-of-period | 259.37 | 16.8 | 76 | 201.7 | |||||
cash-flows.row.cash-at-beginning-of-period | 318.51 | 76 | 201.7 | 12.2 | |||||
cash-flows.row.operating-cash-flow | -73.65 | -73.6 | -87.1 | -51.7 | |||||
cash-flows.row.capital-expenditure | -0.97 | -1 | -6 | -4.9 | |||||
cash-flows.row.free-cash-flow | -74.62 | -74.6 | -93.1 | -56.6 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 2.91 | 2.9 | 0.8 | 0 | |||||
income-statement-row.row.cost-of-revenue | 3.47 | 3.5 | 0.8 | 1.1 | |||||
income-statement-row.row.gross-profit | -0.56 | -0.6 | 0 | -1.1 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 47.76 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0.4 | |||||
income-statement-row.row.operating-expenses | 102.24 | 102.2 | 93.5 | 61.3 | |||||
income-statement-row.row.cost-and-expenses | 105.71 | 105.7 | 94.3 | 61.3 | |||||
income-statement-row.row.interest-income | 9.08 | 9.1 | 3.4 | 0.3 | |||||
income-statement-row.row.interest-expense | 1.1 | 1.1 | 0.8 | 0.8 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 7.98 | 8 | 2.6 | -37.5 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0.4 | |||||
income-statement-row.row.total-operating-expenses | 7.98 | 8 | 2.6 | -37.5 | |||||
income-statement-row.row.interest-expense | 1.1 | 1.1 | 0.8 | 0.8 | |||||
income-statement-row.row.depreciation-and-amortization | 9.23 | 7.2 | 3.4 | 0.7 | |||||
income-statement-row.row.ebitda-caps | -86.5 | - | - | - | |||||
income-statement-row.row.operating-income | -102.8 | -102.8 | -93.5 | -61.3 | |||||
income-statement-row.row.income-before-tax | -94.82 | -94.8 | -90.9 | -98.8 | |||||
income-statement-row.row.income-tax-expense | 5.59 | 9.1 | -2.6 | 0.1 | |||||
income-statement-row.row.net-income | -93.33 | -94.8 | -88.3 | -98.9 |
Често задавани въпроси
Какво е Singular Genomics Systems, Inc. (OMIC) общи активи?
Singular Genomics Systems, Inc. (OMIC) общите активи са 265467000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 1543000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е -1.014.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е -1.014.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -32.063.
Какъв е общият приход на предприятието?
Общият приход е -35.315.
Каква е Singular Genomics Systems, Inc. (OMIC) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -94820000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 75288000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 102243000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 16233000.000.